Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 3
2003 1
2004 5
2005 9
2006 7
2007 7
2008 14
2009 7
2010 3
2011 4
2012 5
2013 4
2014 2
2015 6
2016 2
2017 3
2018 5
2019 5
2020 8
2021 9
2022 3
2023 8
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
A prospective, iterative, adaptive trial of carfilzomib-based desensitization.
Tremblay S, Driscoll JJ, Rike-Shields A, Hildeman DA, Alloway RR, Girnita AL, Brailey PA, Woodle ES. Tremblay S, et al. Among authors: girnita al. Am J Transplant. 2020 Feb;20(2):411-421. doi: 10.1111/ajt.15613. Epub 2019 Oct 23. Am J Transplant. 2020. PMID: 31550069 Free PMC article. Clinical Trial.
Competing Engagement of β-arrestin Isoforms Balances IGF1R/p53 Signaling and Controls Melanoma Cell Chemotherapeutic Responsiveness.
Cismas S, Pasca S, Crudden C, Trocoli Drakensjo I, Suleymanova N, Zhang S, Gebhard B, Song D, Neo S, Shibano T, Smith TJ, Calin GA, Girnita A, Girnita L. Cismas S, et al. Among authors: girnita a. Mol Cancer Res. 2023 Dec 1;21(12):1288-1302. doi: 10.1158/1541-7786.MCR-22-0871. Mol Cancer Res. 2023. PMID: 37584671 Free article.
ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies.
Kongtim P, Vittayawacharin P, Zou J, Srour S, Shaffer B, Shapiro RM, Varma A, McGuirk J, Dholaria BR, McCurdy SR, DeZern AE, Bejanyan N, Bashey A, Furst S, Castagna L, Mariotti J, Ruggeri A, Bailen R, Teshima T, Xiao-Jun H, Bonfim C, Aung F, Cao K, Carpenter PA, Hamadani M, Askar M, Fernandez-Vina M, Girnita A, Ciurea SO. Kongtim P, et al. Among authors: girnita a. Transplant Cell Ther. 2024 Dec;30(12):1139-1154. doi: 10.1016/j.jtct.2024.09.005. Epub 2024 Sep 10. Transplant Cell Ther. 2024. PMID: 39260570 Review.
Proteasome inhibitor therapy for antibody-mediated rejection.
Woodle ES, Walsh RC, Alloway RR, Girnita A, Brailey P. Woodle ES, et al. Among authors: girnita a. Pediatr Transplant. 2011 Sep;15(6):548-56. doi: 10.1111/j.1399-3046.2011.01543.x. Pediatr Transplant. 2011. PMID: 21884344 Review.
Mohs micrographic surgery revisited: A multidisciplinary, collaborative approach for the treatment of aggressive and recurrent basal cell carcinoma on the head and neck.
Aristokleous I, Schultz I, Vassilaki I, Krynitz B, Lapins J, Girnita A, Nilsson MF. Aristokleous I, et al. Among authors: girnita a. J Plast Reconstr Aesthet Surg. 2022 Sep;75(9):3373-3383. doi: 10.1016/j.bjps.2022.04.037. Epub 2022 Apr 25. J Plast Reconstr Aesthet Surg. 2022. PMID: 35643596
111 results